Rigel Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS (Tables)

CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS (Tables)

12 Months Ended

Dec. 31, 2014

CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS

Schedule of cash, cash equivalents and short-term investments

Cash, cash equivalents and short-term investments consist of the following (in thousands):

	December 31,
	2014		2013
Checking account	$	175	$	195
Money market funds		10,027		9,059
U. S. treasury bills		2,010		2,085
Government-sponsored enterprise securities		45,786		67,178
Corporate bonds and commercial paper		85,161		133,458

	$	143,159	$	211,975


Reported as:
Cash and cash equivalents	$	15,203	$	20,854
Short-term investments		127,956		191,121

	$	143,159	$	211,975

Schedule of cash equivalents and short-term investments including the securities with unrealized gains and losses

Cash equivalents and short-term investments included the following available-for-sale securities with unrealized gains and losses (in thousands):

December 31, 2014	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
U. S. treasury bills	$	2,010	$	—	$	—		$	2,010
Government-sponsored enterprise securities		45,793		4		(11	)		45,786
Corporate bonds and commercial paper		85,161		21		(21	)		85,161

Total	$	132,964	$	25	$	(32	)	$	132,957

December 31, 2013	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
U. S. treasury bills	$	2,083	$	2	$	—		$	2,085
Government-sponsored enterprise securities		67,160		29		(11	)		67,178
Corporate bonds and commercial paper		133,431		33		(6	)		133,458

Total	$	202,674	$	64	$	(17	)	$	202,721

Schedule of fair value and gross unrealized losses of the entity's investments in unrealized loss position

The following table shows the fair value and gross unrealized losses of our investments in individual securities that are in an unrealized loss position, aggregated by investment category (in thousands):

December 31, 2014	Fair Value		Unrealized Losses
Government-sponsored enterprise securities	$	23,122	$	(11	)
Corporate bonds and commercial paper		34,441		(21	)

Total	$	57,563	$	(32	)